Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on ALXN, DOLE, HLIT and NKE Issued by the Bedford Report

DOLE, HLIT, NKE
Free Research Reports on ALXN, DOLE, HLIT and NKE Issued by the Bedford Report

NEW YORK, NY -- (Marketwired) -- 05/29/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares have gained approximately 7.5 percent year-to-date. The company recently announced that the U.S. Food and Drug Administration have granted Breakthrough Therapy designation to asfotase alfa for the treatment of hypophosphatasia, a rare metabolic disorder.

Find out more about Alexion Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/ALXN

Dole Food Company, Inc. (NYSE: DOLE) shares dropped over 6.0 percent on more than double the average daily volume Tuesday. The company announced the "indefinite suspension" of its $200 million share repurchase program as they begin to focus on upgrading their shipping fleet.

Find out more about Dole Food Company including full access to the free equity report at: www.BedfordReport.com/DOLE

Harmonic Inc. (NASDAQ: HLIT) shares traded in the range of $6.13 to $6.40 Tuesday and have gained approximately 22 percent year-to-date. Preliminary results from Harmonic's Dutch auction showed the company expects to acquire roughly 12 million shares of its common stock at a price of $6.25 per share.

Find out more about Harmonic including full access to the free equity report at: www.BedfordReport.com/HLIT

NIKE, Inc. (NYSE: NKE) shares have gained approximately 22.0 percent year-to-date. The company announced Tuesday that it has cut ties with the Livestrong foundation, which it has helped raise over $100 million for over the years. Nike currently offers investors an annual dividend of $0.84, for a dividend yield of roughly 1.35 percent.

Find out more about NIKE including full access to the free equity report at: www.BedfordReport.com/NKE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.